Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
Clinical trial NCT00728078 · UNKNOWN
Trial details
- NCT number
- NCT00728078
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.